A comparative study of interferon-beta products for relapsing-remitting multiple sclerosis: QUASIMS results from Italy

被引：0
|
作者：
Lugaresi, A
机构：
来源：
JOURNAL OF NEUROLOGY | 2005年 / 252卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [41] Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis
    Greenberg, Benjamin M.
    Balcer, Laura
    Calabresi, Peter A.
    Cree, Bruce
    Cross, Anne
    Frohman, Teresa
    Gold, Ralf
    Havrdova, Eva
    Hemmer, Bernhard
    Kieseier, Bernd C.
    Lisak, Robert
    Miller, Aaron
    Racke, Michael K.
    Steinman, Lawrence
    Stuve, Olaf
    Wiendl, Heinz
    Frohman, Elliot
    [J]. JAMA NEUROLOGY, 2013, 70 (02) : 248 - 251
  • [42] Impact of discontinuing interferon beta in patients with relapsing-remitting multiple sclerosis
    Agiela, Mabroka I. M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP5 - NP5
  • [43] Predicting beta-interferon failure in relapsing-remitting multiple sclerosis
    O'Rourke, K.
    Walsh, C.
    Antonelli, G.
    Hutchinson, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (03) : 336 - 342
  • [44] BEST PRACTICES FOR NETWORK META-ANALYSIS METHODOLOGY: COMPARATIVE EFFECTIVENESS OF INTERFERON-BETA THERAPIES IN RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Beckerman, R.
    Locklear, J. C.
    Jiang, Y.
    Solon, C.
    Smith, N. J.
    Phillips, A. L.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A696 - A696
  • [45] Interferon-beta and worsening disability in relapsing-remitting multiple sclerosis: 10-year follow-up study
    Drulovic, J.
    Mesaros, S.
    Dujmovic, I.
    Martinovic, V.
    Pekmezovic, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 790 - 791
  • [46] Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
    Cocco, Eleonora
    Marrosu, Maria Giovanna
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 759 - 766
  • [47] The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis
    Madsen, Claus
    [J]. BRAIN AND BEHAVIOR, 2017, 7 (06):
  • [48] Effectiveness of interferon beta treatment in relapsing-remitting multiple sclerosis: an Italian cohort study
    Russo, P
    Paolillo, A
    Caprino, L
    Bastianello, S
    Bramanti, P
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2004, 10 (04) : 511 - 518
  • [49] Minimal change disease with interferon-beta therapy for relapsing remitting multiple sclerosis
    Aravindan, Ananthakrishnapuram
    Yong, Jim
    Killingsworth, Murray
    Suranyi, Michael
    Wong, Jeffrey
    [J]. CLINICAL KIDNEY JOURNAL, 2010, 3 (02): : 132 - 134
  • [50] Results from the global QUASIMS study:: Comparison of the efficacy and tolerability of interferon beta (IFNb) products for the treatment of relapsing multiple sclerosis in Australia, Brazil, Belgium, Italy and Slovakia
    Limmroth, V
    Wernek, L
    Nagels, G
    Lugaresi, A
    Kalski, G
    Wernsdörfer, C
    [J]. NEUROLOGY, 2005, 64 (06) : A325 - A326
12345